Tag Archives: BIO EVENT

Benefiting from Innovative Clinical Trial Designs


Clinical trial success rates have been known to be low for some time now, but that does not imply they will remain low forever. As more tools become available to clinical trial sponsors, technical operators and even patients, future clinical success may look nothing like it has over the last decade. Taking steps to change old fashioned protocols were panelist that gathered for today’s panel on clinical trial innovation trends at the BIO Investor Forum Read More >

Events  |  Leave a comment  |  Email This Post
Tags: , , , , , ,

Small Company with Big Dreams – #BIF16 Fireside Chat with Rachel Haurwitz


Rachel Haurwitz is young. So is her company. Caribou was founded in 2011 and Haurwitz became the CEO in 2012 when she finished her PhD. In 2014 Haurwitz landed on  FORBES 30 Under 30 list for Science & Healthcare. And then in 2016 she was selected for Fortune magazine’s 2016 “40 Under 40” list, the publication’s annual ranking of the most influential young people in business. During a Fireside Chat today at the BIO Investor Forum, Read More >

Business of Biotech  |  Leave a comment  |  Email This Post
Tags: , , , , , , , ,

A Neuroscience Fireside Chat with Ryan Watts at 2016 BIO Investor Forum


The 2106 BIO Investor Forum held a Fireside Chat with Ryan Watts, PhD on Tuesday, October 18 moderated by: Andrew Fein, Managing Director and Senior Healthcare Analyst, Research Division at H.C. Wainwright & Co., LLC. Rachel Lane, PhD, Equity Research, Biotechnology at H.C. Wainwright & Co., LLC Ryan Watts, PhD, is the current Chief Executive Officer at Denali Therapeutics Inc. in addition to being a co-founder and a member of the Board of Directors. Previously, Read More >

Events  |  Leave a comment  |  Email This Post
Tags: , , ,

Does Big Company M&A Impact Small Company M&A?


Over the last few years, we have seen significant consolidation among the large drug manufacturers, with both franchise swapping and mergers of equals – but what is the impact on small biotechs? At the BIO Investor Forum, (held at the Westin St. Francis in San Francisco today), a panel session moderated by Matthew Hudes, Chief Executive Officer of bdlBiologx, set out to answer that very question. The panelists, all seasoned industry veterans, came from a Read More >

Business and Investments, Events  |  Leave a comment  |  Email This Post
Tags: , , , , , , , , ,

BIO Investor Forum Session on Advancing Immuno–Oncology

At the 2016 BIO Investor Forum, the first session held was titled “The Intersection of Inflammation and Immuno-Oncology: Risks and Opportunities.” Moderated by Michael King, Managing Director and Senior Research Analyst at JMP Securities, panelist included: Jay Venkatesan, MD, President & Director, Alpine Immune Sciences Pablo Cagnoni, MD, President & Chief Executive Officer, Tizona Therapeutics Alex Szidon, PhD, Executive Director, Business Development & Licensing; Head of West Coast Innovation Hub, Merck & Co. Inc. Paul Read More >

Events, Health  |  Leave a comment  |  Email This Post
Tags: , , , , , , , , ,